SYNT Stock Overview
Engages in the development and marketing of imaging and software solutions for magnetic resonance imaging (MRI) in Sweden and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
SyntheticMR AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 27.70 |
| 52 Week High | SEK 34.90 |
| 52 Week Low | SEK 17.30 |
| Beta | 0.96 |
| 1 Month Change | 0% |
| 3 Month Change | 1.09% |
| 1 Year Change | -13.44% |
| 3 Year Change | -40.69% |
| 5 Year Change | 6.54% |
| Change since IPO | 1,008.00% |
Recent News & Updates
Recent updates
Should You Think About Buying SyntheticMR AB (publ) (NGM:SYNT) Now?
Dec 20
What Does SyntheticMR AB (publ)'s (NGM:SYNT) Share Price Indicate?
Sep 21Some Investors May Be Worried About SyntheticMR's (NGM:SYNT) Returns On Capital
Mar 18There Are Reasons To Feel Uneasy About SyntheticMR's (NGM:SYNT) Returns On Capital
Nov 29What Does SyntheticMR AB (publ)'s (NGM:SYNT) Share Price Indicate?
Aug 06Why SyntheticMR AB (publ) (NGM:SYNT) Could Be Worth Watching
Feb 23A Look At The Intrinsic Value Of SyntheticMR AB (publ) (NGM:SYNT)
Jan 27Should You Think About Buying SyntheticMR AB (publ) (NGM:SYNT) Now?
Nov 10Read This Before Selling SyntheticMR AB (publ) (NGM:SYNT) Shares
Mar 09Shareholder Returns
| SYNT | SE Healthcare Services | SE Market | |
|---|---|---|---|
| 7D | 0% | 9.9% | 3.5% |
| 1Y | -13.4% | 35.9% | -5.3% |
Return vs Industry: SYNT underperformed the Swedish Healthcare Services industry which returned 34.5% over the past year.
Return vs Market: SYNT underperformed the Swedish Market which returned 8.6% over the past year.
Price Volatility
| SYNT volatility | |
|---|---|
| SYNT Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 6.3% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in SE Market | 13.7% |
| 10% least volatile stocks in SE Market | 4.1% |
Stable Share Price: SYNT has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SYNT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 37 | Ulrik Harrysson | www.syntheticmr.com |
SyntheticMR AB (publ) engages in the development and marketing of imaging solutions for magnetic resonance imaging (MRI) in Sweden, the Middle East, Africa, Europe, North America, South America, and the Asia-Pacific. Its SyMRI delivers various contrast images, biomarker segmentations, and quantitative data with a single MR sequence. The company also offers SyMRI NEURO includes contrast weighted images, as well as biomarker segmentation, volumetric measurements of brain tissues and parametric maps that provide objective decision support for the diagnosis and follow-up of patients; SyMRI MSK works on a range of anatomies, and provides quantitative T1, T2, and PD maps, as well as multiple contrast-weighted images; and MAGiC, a customer-specific version of SyMRI IMAGE.
SyntheticMR AB (publ) Fundamentals Summary
| SYNT fundamental statistics | |
|---|---|
| Market cap | SEK 1.15b |
| Earnings (TTM) | SEK 10.01m |
| Revenue (TTM) | SEK 94.37m |
115.3x
P/E Ratio12.2x
P/S RatioIs SYNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SYNT income statement (TTM) | |
|---|---|
| Revenue | SEK 94.37m |
| Cost of Revenue | SEK 30.33m |
| Gross Profit | SEK 64.05m |
| Other Expenses | SEK 54.03m |
| Earnings | SEK 10.01m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 21, 2024
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 67.86% |
| Net Profit Margin | 10.61% |
| Debt/Equity Ratio | 0% |
How did SYNT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/04/29 13:49 |
| End of Day Share Price | 2024/01/31 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SyntheticMR AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Simon Larsson | Danske Bank |
| Christian Lee | Pareto Securities |